| Having trouble viewing this email? Click here |
![]() |
||||
| Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years. | ||||
|
SUMMARY OF TOP ARTICLES - AUGUST 28, 2014
Weighing Pradaxa’s Risks New York Times - August 18, 2014 Patients taking traditional blood thinners like warfarin must have tests every few weeks to ensure that blood levels of the drug are in an acceptable range. But 2010 brought a seemingly welcome alternative: Pradaxa. In Move to Curb Drug Abuse, D.E.A. Tightens Rule on Widely Prescribed Painkiller New York Times - August 21, 2014 The federal government tightened the prescribing for the most common form of painkiller in the country on Thursday, the final step in a policy shift that has been years in the making. California legislators approve naloxone dispensing without Rxs Drug Topics - August 20, 2014 California lawmakers recently passed a bill that would allow pharmacists to furnish naloxone without a prescription according to guidelines yet to be established by the state’s pharmacy and medical boards. Early Research With Drug Restores Hair in Patients With Alopecia HealthDay News - March 00, 2014 A drug used to treat a rare type of bone marrow cancer restores hair in patients with an autoimmune disease that causes hair loss, a new study found. 'Off-label' use to treat dementia-related behavior may carry significant risks, study finds HealthDay News - August 19, 2014 Kidney injury can be added to the list of possible harms related to use of three antipsychotic medications often prescribed to treat behavioral symptoms of dementia in older adults, a new study finds. OIG finds risk of abuse in specialty pharmacy’s per-fill fee proposal Lexology - August 22, 2014 In an Advisory Opinion posted August 15, 2014, the Office of Inspector General (“OIG”) concluded that a proposed arrangement by a specialty pharmacy (“Requestor”) might generate prohibited remuneration under the Federal anti-kickback statute and would pose a risk of fraud and abuse. Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug Fortune - August 25, 2014 Deal gives the Swiss pharmaceutical giant access to InterMune’s innovative therapies. Nonprofit Hospitals’ 2013 Revenue Lowest Since Recession, Report Says New York Times - August 27, 2014 Nonprofit hospitals last year had their worst financial performance since the Great Recession, according to a report released on Wednesday. The poor operating performance of many hospitals underscored some of the changes in the health care system as the federal government and private health plans became less willing to pay for hospital care and changed the way they paid hospitals in an effort to reduce costs. New statin guidelines an improvement, study shows ScienceDaily - August 26, 2014 New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a study has found. The research also showed the new guidelines produce only a modest increase in the number of patients being given the drugs. The Affordable Care Act supports patient-centered medical homes in health centers U.S. Department of Health & Human Services - August 26, 2014 Obama administration awards over $35 million to support facility improvements in 147 health centers nationwide to deliver better coordinated care Big Drop in U.S. Heart-Related Hospitalizations and Deaths, Study Finds HealthDay News - August 18, 2014 Lifestyle changes, wider use of medications driving the trend, researchers say. Cancer-fighting drugs might also stop malaria early ScienceDaily - August 25, 2014 Scientists searching for new drugs for malaria have identified a number of compounds -- some of which are in clinical trials to treat cancer -- that could lead to new ways to fight the disease. Researchers identified 31 enzyme-blocking molecules, called protein kinase inhibitors, that curb malaria before symptoms start. By focusing on treatments that act early, the researchers hope to give drug-resistant strains less time to spread. Contact, Kristin LaVitola Marketing Director, PSG Pharmaceutical Strategies Group (PSG) Office: 972-244-8388 Email: KLavitola@PSGConsults.com PSGNewsletter@PSGConsults.com www.PSGConsults.com |
||||